High toxicity profiles of oral oncolytic medications (OAMs) can lead to decreased time on therapy.
Medication persistence can be improved through high-touch communication between patients and pharmacists. With earlier touch points, pharmacists are more likely to identify patient-related challenges to therapy.
Clinical care management and reporting platforms like TherigySTM℠ have allowed for the development of health system specialty pharmacy (HSSP) protocolized check-ins.
To evaluate the outcomes of an HSSP-led 7- to 14-day check-in protocol, using TherigySTM, on identifying and addressing early side effects of OAMs.
Read the Outcomes Study by submitting the form below.